Latest News
Ministerial Committee on Commercialization of Phytomedicine Value ChainMinisterial Working Visit to NIPRDWebinar Conference on Expediting Local Vaccines’ Manufacturing in NigeriaPharma Industry Engagement (WHO PQ Capacity Building Programme)NIPRD signs MoU with FMSDIGA and NLTF on CPP

Analytical Research
Contextualizing Research Processes
Pharma Industry Engagement
Hon Minister of State for Health, Dr Iziaq A. Salako in a conversation with Dr Obi Adigwe, Director-General of NIPRD during Industry Engagement with Top Pharma Manufacturers
NIPRD Laboratory Complex
Head office of the National Institute for Pharmaceutical Research and Development
International Collaboration
Chief Diana Chen, Chair CABC Collaborative Visit to DG NIPRD
Partnership Engagement
Robust Inter-governmental Agency Collaboration
Pharma Industry Engagement
WHO PQ Capacity Building Programme
High-Level Dialogue
Ministerial Engagement to address tech gaps in Nigeria's Pharmac and Vaccine industries
High-Level Engagement
Dr Obi Adigwe, DG NIPRD with Prof Akin Abayomi, Hon Commissioner of Health, Lagos State during a High-Level Meeting with Top Pharma Manufacturers and other Stakeholders

Welcome message from the Director-General / CEO

The National Institute for Pharmaceutical Research and Development (NIPRD) is a Federal Government Parastatal under the Federal Ministry of Health. The Agency was established by Government Order No. 33 Vol. 74 of 11th June 1987 Part B under the Science and Technology Act Cap 276. It became functional in the year 1989. In 2001 following a Federal Executive Council decision, NIPRD was moved to the Federal Ministry of Health (FMOH), with a huge investment in scientific equipment and human resources. 

NIPRD is the only one of its kind in the Region, and is statutorily charged with the responsibility for research and development of drugs, vaccines, phytomedicines, commodities, and diagnostics aimed at improving sustainable access to safe, affordable and high-quality healthcare. Read more…
Latest Media Engagement
"Part of Mr President’s aim in approving the “Unlocking Healthcare Value Chain Initiative”, as part of Nigeria’s Health Sector Renewal Programme, is to optimize end-to-end R&D pathways for addressing priority diseases in Nigeria."
Prof Muhammad Ali Pate
Prof Muhammad Ali PateCoordinating Minister of Health and Social Welfare, Nigeria
"Our healthcare sector, particularly the pharmaceutical value chain, must be strengthened to ensure we are not only meeting domestic demand but also becoming competitive players in the global market."
Dr. Iziaq A. Salako
Dr. Iziaq A. SalakoHon. Minister of State for Health and Social Welfare, Nigeria
"We will do our very best to give legislative backing to enable you perform your duties."
Sen. Dr. Ipalibo Banigo
Sen. Dr. Ipalibo BanigoChair, Senate Committee on Health (Secondary and Tertiary)

FG moves to unlock economic, health potential of Nigerian phytomedicines

Click on the image above, to participate in the study to assess the perceptions, experiences and insights of key stakeholders regarding the development, integration and commercialization of phytomedicines in Nigeria.

Get our COVID-19 Advisory

NSP-II (2021 - 2025)

M&E Plan (2021 - 2025)

MEDIA

Africa no longer has an interest in tokenistic interventions such as fill-finish products, but has become interested in building dependable, equitable, and veracious partnerships that will enable the Continent to undertake full R&D for the production of vaccines.

Dr Obi Adigwe, DG NIPRD Tweet

Our Partners ... The list keeps growing !

AEFU-NAI
Coat of Arm[2]
FUD
Katsina State Govt
KDSG
M&B
Malaria Consortium
NAPSSA
NCC
USP
WAHO

Useful Links

e-Herbarium
FOI Act
JOPAT
Publications